Literature DB >> 22294800

A clinical oncology case report.

Akiko Koshino1, Glenna E Mauldin, Ryan M Dickinson, G Neal Mauldin.   

Abstract

Mesh:

Year:  2011        PMID: 22294800      PMCID: PMC3135040     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


× No keyword cloud information.
  3 in total

1.  Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs.

Authors:  A K Patnaik; W J Ehler; E G MacEwen
Journal:  Vet Pathol       Date:  1984-09       Impact factor: 2.221

2.  Masitinib is safe and effective for the treatment of canine mast cell tumors.

Authors:  K A Hahn; G Ogilvie; G Oglivie; T Rusk; P Devauchelle; A Leblanc; A Legendre; B Powers; P S Leventhal; J-P Kinet; F Palmerini; P Dubreuil; A Moussy; O Hermine
Journal:  J Vet Intern Med       Date:  2008-09-24       Impact factor: 3.333

3.  Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision.

Authors:  Cheryl A London; Phyllis B Malpas; Stacey L Wood-Follis; Joseph F Boucher; Anthony W Rusk; Mona P Rosenberg; Carolyn J Henry; Kathy L Mitchener; Mary K Klein; John G Hintermeister; Philip J Bergman; Guillermo C Couto; Guy N Mauldin; Gina M Michels
Journal:  Clin Cancer Res       Date:  2009-05-26       Impact factor: 12.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.